News

As chronicled by iPolitics yesterday, with the rare, but not unprecedented support of the Conservatives, the government’s bid ...
Oklahoma Attorney General Gentner Drummond filed a federal lawsuit to block 23andMe, a genetic testing company, from selling ...
OpenAI's effort could involve seeking a federal regulatory review of the terms of its contract with Microsoft for potential violations of antitrust law, as well as a public campaign, the report said.
In a significant turn of events, Ann Wojcicki's non-profit, TTAM Research Institute, has secured a deal to purchase the ...
U.S. Rep. Alexandria Ocasio-Cortez (D-NY), whose district includes parts of the Bronx and Queens, is leading a congressional ...
Three years after litigation started over technology used in Comirnaty, the mRNA vaccine for COVID-19, Biontech SE is acquiring its adversary, Curevac NV, through an all-stock transaction valued at ...
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate ...
Defense Secretary Pete Hegseth was quickly met with sharp questions and criticism Tuesday by lawmakers who pressed him about his early moves to deploy troops to Los ...
NEW YORK (Reuters) -Bankrupt genetic testing company 23andMe told a U.S. bankruptcy judge on Wednesday that it wants to ...
In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...
A biotech future built on data: Regeneron’s acquisition of 23andMe blurs the line between pharmaceutical innovation and genetic surveillance. Unsplash+ “We are pleased to have reached a ...
Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.